Freiburg, Germany: November 13, 2024 - StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is excited to announce their European division will be relocating.
Brian is a valuable Research Scientist on the StageBio team.
Mt. Jackson, VA – October 7, 2024: StageBio pathologist Olivia Patania, DVM, PhD, DACVP, will co-host a breakfast and networking event for veterinary students at the American College of Veterinary Pathologists (ACVP) 2024 Annual Meeting.
Erin Holt has been a valuable member of the StageBio team as a Lead Research Associate.
Mt. Jackson, VA – October 1, 2024: StageBio Senior Director of Medical Device & Neuropathy Sarah Cramer, DVM, PhD, DACVP, will co-present a Continuing Education course at the American College of Toxicology (ACT) 45th Annual Meeting in Austin, Texas.
Meet StageBio’s featured pathologist, Dr Lynette Phillips, DVM, PhD, DACVP!
Meet Mt. Jackson, VA – August 5, 2024: StageBio is attending the 5th Cutting Edge Pathology Congress (CEP) in San Lorenzo de El Escorial (Madrid), Spain.
Meet our featured StageBio pathologist, Dr Lemarchand from Germany! Thomas Xavier Lemarchand, DVM, PhD, DECVP, DESVpath, Director of Digital and Quantitative Pathology. How long have you worked with StageBio? Over 8 years, ever since our Freiburg team joined StageBio in 2020; so, about half with TPL Path labs GmbH, about half with StageBio.
StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is pleased to welcome Shehnaz Kataria to the executive team as Chief Financial Officer.
Anyone developing study protocols and study design knows that components of a thorough safety assessment vary due to any number of factors.
513.204.4400
